Celgene Corporation (NASDAQ:CELG) Given a $162.00 Price Target at Cantor Fitzgerald

Celgene Corporation (NASDAQ:CELG) Given a $162.00 Price Target at Cantor Fitzgerald

(NASDAQ:CELG) last announced its quarterly earnings data on Thursday, October 27th.

Westwood Management Corp decreased Celgene Corp.

Meyer Handelman Co increased General Electric Corp Com (GE) stake by 1.08% reported in 2017Q2 SEC filing. (AMGN)'s stock declined 9.68%. Waldron LP now owns 5,207 shares of the biopharmaceutical company's stock valued at $640,000 after buying an additional 1,709 shares during the last quarter. The Stock has YTD (year to date) performance of -13.62 percent. The company's stock had a trading volume of 24,135,277 shares.

Celgene Corporation (NASDAQ:CELG) received a $162.00 price target from stock analysts at Cantor Fitzgerald in a report released on Monday, October 16th. 0 analysts gave its stock an Outperform rating.

Investors sentiment increased to 1.34 in Q2 2017. Its up 0.21, from 1.13 in 2017Q1. It worsened, as 72 investors sold AMGN shares while 463 reduced holdings. 97 funds opened positions while 651 raised stakes. In the last three months, insiders sold 46,233 shares of company stock valued at $6,268,259. Nichols & Pratt Advisers Ltd Liability Partnership Ma holds 439,792 shares. Foundation Resources Mgmt Inc stated it has 1.9% of its portfolio in Intel Corporation (NASDAQ:INTC). It also reduced U.S. Bancorp (NYSE:USB) stake by 11,088 shares and now owns 460,945 shares. Ontario Teachers Pension Plan Board owns 173,698 shares for 0.27% of their portfolio. Kimelman And Baird Ltd Limited Liability Company invested in 0.05% or 2,700 shares. Legacy Capital Prtnrs accumulated 2.07% or 29,520 shares. Allstate reported 0.13% stake. Advisors Asset Management Inc. boosted its position in shares of Celgene Corporation by 6.6% during the first quarter.

The company now has an insider ownership of 0.2 Percent and Institutional ownership of 81.6 Percent. Signaturefd Ltd Liability holds 0.15% of its portfolio in Intel Corporation (NASDAQ:INTC) for 30,797 shares. Susquehanna Intl Gru Llp invested 0% of its portfolio in bluebird bio Inc (NASDAQ:BLUE). The shares were sold at an average price of $143.89, for a total value of $248,498.03. It also upped Spdr S&P 500 Etf Tr (Call) stake by 150,000 shares and now owns 500,000 shares.

Among 20 analysts covering Ally Financial (NYSE:ALLY), 15 have Buy rating, 1 Sell and 4 Hold. Therefore 50% are positive. The company was maintained on Thursday, June 1 by Mizuho. The firm found the stock of CELG quite attractive and now has a PT of $160 with a key "Buy" rating. Liberum Capital maintained Go-Ahead Group plc (LON:GOG) rating on Monday, January 23. The firm has "Equal-Weight" rating given on Friday, October 20 by Barclays Capital.

Spain deny Mali another World Cup final
The match is nicely poised as the battle between football's two big virtues: Mali's relentless attack and Spain's resilience. Spain added a third with 20 minutes to play through Ferran Torres .

10/26/2017-Cann Reiterated Rating of Buy. The firm has "Outperform" rating by Credit Suisse given on Wednesday, January 20.

CELG has been the topic of several other research reports. During the same quarter in the previous year, the business posted $1.58 earnings per share.

Average Revenue Estimate for the current quarter is $3.58 Billion, according to consensus forecast of 25 analysts.

Investors sentiment increased to 1.34 in 2017 Q2. Its up 0.21, from 1.13 in 2017Q1. It is positive, as 60 investors sold Celgene Corporation shares while 390 reduced holdings. C Wide Grp Holding A S invested in 184,063 shares or 0.36% of the stock. Ci Inc holds 0.9% or 3.09 million shares in its portfolio. Avalon Advisors Ltd Liability Corp has invested 0.41% of its portfolio in Celgene Corporation (NASDAQ:CELG). Thompson Davis Inc holds 0.16% in Celgene Corporation (NASDAQ:CELG) or 773 shares. Arizona State Retirement stated it has 193,618 shares. Clearbridge Investments LLC now owns 4,601,919 shares of the biopharmaceutical company's stock valued at $572,617,000 after buying an additional 892,392 shares during the last quarter. 9,009 are owned by Security Trust. Smithfield Trust Co. now owns 1,282 shares of the biopharmaceutical company's stock valued at $127,000 after buying an additional 142 shares during the period. Torch Wealth Limited Co reported 105,562 shares. Cowen & Co maintained the shares of CELG in report on Friday, August 4 with "Buy" rating. Tru Com Of Toledo Na Oh reported 6,003 shares or 0.2% of all its holdings. Millie Capital Management LLC now owns 30,670 shares of the biopharmaceutical company's stock worth $3,816,000 after acquiring an additional 136 shares during the period. The New York-based Basswood Capital Management L.L.C. has invested 0.68% in the stock. Hartford Invest Management reported 0.43% stake. Therefore 65% are positive. The stock has "Buy" rating by Stifel Nicolaus on Friday, July 28. Jefferies Group LLC reaffirmed a "buy" rating and set a $160.00 price objective on shares of Celgene Corporation in a research note on Tuesday, July 11th. BTIG Research downgraded the shares of CELG in report on Wednesday, June 1 to "Neutral" rating. Dixon Hubard Feinour & Brown Inc Va has invested 0.07% in Celgene Corporation (NASDAQ:CELG). The firm has "Buy" rating by Liberum Capital given on Tuesday, October 20. The stock of Celgene Corporation (NASDAQ:CELG) earned "Buy" rating by Citigroup on Thursday, February 25. As per Wednesday, July 12, the company rating was maintained by Oppenheimer. The firm has "Hold" rating given on Friday, May 5 by Argus Research. The rating was maintained by Canaccord Genuity on Monday, October 16 with "Buy". Universal Display Corp. (NASDAQ:OLED) was raised too.

Since June 15, 2017, it had 0 insider purchases, and 3 sales for $2.36 million activity. The insider CASEY MICHAEL D sold 9,250 shares worth $1.16M. VESSEY RUPERT had sold 4,785 shares worth $575,038 on Thursday, June 15.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related Articles